Clinical Implication of Surgical Resection for Recurrent Biliary Tract Cancer: Does It Work or Not?

Overview

Journal Ann Gastroenterol Surg

Date 2018 Jun 5

PMID 29863155

Citations 7

Authors

Masaru Miyazaki

Hiroaki Shimizu

Hideyuki Yoshitomi

Atsushi Kato

Katsunori Furukawa

Tsukasa Takayashiki

Satoshi Kuboki

Shigetsugu Takano

Masayuki Ohtsuka

Affiliations

Soon will be listed here.

Abstract

Although recent advances in imaging diagnosis, surgical techniques, and perioperative management can result in increased resectability and improved surgical outcomes, most resected patients still develop cancer recurrence. If patients develop cancer recurrence, their prognosis is very ominous. However, there have been some recent reports to show promising outcomes by aggressive surgical strategy in selected patients who developed cancer recurrence. Because there are various surgical procedures being selected at initial surgery in patients with biliary tract cancers, recurrent patterns after resection are very variable in each patient. However, surgical procedures might usually be very complicated and difficult if re-surgical resection is considered in patients with recurrent biliary tract cancer, Therefore, surgical re-resection could bring about high surgical morbidity and mortality rates in most previously reported series. Although re-surgical resection might offer a chance of favorable outcome in selected patients with biliary tract cancers, these aggressive surgical approaches should be carried out in strictly selected patients by expert surgeons at high-volume centers.

Citing Articles

Integrative genomic analyses of European intrahepatic cholangiocarcinoma: Novel ROS1 fusion gene and PBX1 as prognostic marker.

Plum P, Hess T, Bertrand D, Morgenstern I, Velazquez Camacho O, Jonas C Clin Transl Med. 2024; 14(6):e1723.

PMID: 38877653 PMC: 11178519. DOI: 10.1002/ctm2.1723.

Current progress in perioperative chemotherapy for biliary tract cancer.

Ioka T, Shindo Y, Ueno M, Nagano H Ann Gastroenterol Surg. 2023; 7(4):565-571.

PMID: 37416744 PMC: 10319609. DOI: 10.1002/ags3.12691.

Surgical treatment for recurrent cholangiocarcinoma: a single-center series.

Fernandez L, Gastaca M, Alonso E, Prieto M, Ruiz P, Ventoso A Front Oncol. 2023; 13:1169133.

PMID: 37143948 PMC: 10152064. DOI: 10.3389/fonc.2023.1169133.

Indications for resection of recurrent lesions in patients with distal cholangiocarcinoma based on prognostic factors: a single-institute retrospective study and brief literature review.

Mashiko T, Ogasawara T, Masuoka Y, Ei S, Takahashi S, Mori M BMC Surg. 2022; 22(1):423.

PMID: 36503431 PMC: 9743743. DOI: 10.1186/s12893-022-01879-3.

Immune checkpoint inhibitors plus capecitabine and oxaliplatin in unresectable or advanced biliary tract cancer patients: A retrospective study.

Zhao J, Guo Y, Ding W, Han G, Jiang C, Yang C Front Oncol. 2022; 12:965711.

PMID: 36276134 PMC: 9582263. DOI: 10.3389/fonc.2022.965711.

References

Jarnagin W, Ruo L, Little S, Klimstra D, DAngelica M, DeMatteo R . Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003; 98(8):1689-700. DOI: 10.1002/cncr.11699. View

Hwang S, Yu Y, Park G, Choi Y, Park P, Jung S . Pancreatoduodenectomy for local intrapancreatic recurrence after bile duct resection of mid bile duct carcinoma. Hepatogastroenterology. 2011; 57(102-103):1040-5. View

Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H . Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg. 2002; 89(12):1525-31. DOI: 10.1046/j.1365-2168.2002.02268.x. View

Yamamoto M, Takasaki K, Otsubo T, Katsuragawa H, Katagiri S . Recurrence after surgical resection of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2001; 8(2):154-7. DOI: 10.1007/s005340170039. View

Chareton B, Coiffic J, Landen S, Bardaxoglou E, Campion J, Launois B . Diagnosis and therapy for ampullary tumors: 63 cases. World J Surg. 1996; 20(6):707-12. DOI: 10.1007/s002689900108. View

Miyazaki M, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Kato A . Recent advance in the treatment of hilar cholangiocarcinoma: hepatectomy with vascular resection. J Hepatobiliary Pancreat Surg. 2007; 14(5):463-8. DOI: 10.1007/s00534-006-1195-0. View

Kamphues C, Seehofer D, Eisele R, Denecke T, Pratschke J, Neumann U . Recurrent intrahepatic cholangiocarcinoma: single-center experience using repeated hepatectomy and radiofrequency ablation. J Hepatobiliary Pancreat Sci. 2010; 17(4):509-15. DOI: 10.1007/s00534-009-0256-6. View

West J, Wood H, Logan R, Quinn M, Aithal G . Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer. 2006; 94(11):1751-8. PMC: 2361300. DOI: 10.1038/sj.bjc.6603127. View

Konstantinidis I, Warshaw A, Allen J, Blaszkowsky L, Fernandez-Del Castillo C, Deshpande V . Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?. Ann Surg. 2012; 257(4):731-6. DOI: 10.1097/SLA.0b013e318263da2f. View

10.

Kondo S, Nimura Y, Kamiya J, Nagino M, Kanai M, Uesaka K . Mode of tumor spread and surgical strategy in gallbladder carcinoma. Langenbecks Arch Surg. 2002; 387(5-6):222-8. DOI: 10.1007/s00423-002-0318-6. View

11.

Jong M, Nathan H, Sotiropoulos G, Paul A, Alexandrescu S, Marques H . Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011; 29(23):3140-5. DOI: 10.1200/JCO.2011.35.6519. View

12.

Targarona E, Zografos G, Habib N . Liver resection for recurrent hilar cholangiocarcinoma. Br J Surg. 1993; 80(11):1433. DOI: 10.1002/bjs.1800801127. View

13.

Choi S, Kim K, Choi J, Park S, Choi J, Lee W . The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol. 2009; 16(11):3048-56. DOI: 10.1245/s10434-009-0631-1. View

14.

Shimizu H, Sawada S, Kimura F, Yoshidome H, Ohtsuka M, Kato A . Clinical significance of biliary vascular anatomy of the right liver for hilar cholangiocarcinoma applied to left hemihepatectomy. Ann Surg. 2009; 249(3):435-9. DOI: 10.1097/SLA.0b013e31819a6c10. View

15.

Boone B, Zeh H, Mock B, Johnson P, Dvorchik I, Lee K . Resection of isolated local and metastatic recurrence in periampullary adenocarcinoma. HPB (Oxford). 2013; 16(3):197-203. PMC: 3945844. DOI: 10.1111/hpb.12119. View

16.

Palta M, Patel P, Broadwater G, Willett C, Pepek J, Tyler D . Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy. Ann Surg Oncol. 2011; 19(5):1535-40. PMC: 4155936. DOI: 10.1245/s10434-011-2117-1. View

17.

Patel T . Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001; 33(6):1353-7. DOI: 10.1053/jhep.2001.25087. View

18.

Morris-Stiff G, Alabraba E, Tan Y, Shapey I, Bhati C, Tanniere P . Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and morphology. Eur J Surg Oncol. 2009; 35(7):746-50. DOI: 10.1016/j.ejso.2008.10.010. View

19.

Yoshidome H, Takeuchi D, Ito H, Kimura F, Shimizu H, Ambiru S . Should the inferior vena cava be reconstructed after resection for malignant tumors?. Am J Surg. 2005; 189(4):419-24. DOI: 10.1016/j.amjsurg.2005.01.010. View

20.

Lee J, Lee S, Lim J, Park J, Yoon D, Kim K . Is Pancreaticoduodenectomy Feasible for Recurrent Remnant Bile Duct Cancer Following Bile Duct Segmental Resection?. J Gastrointest Surg. 2015; 19(12):2138-45. DOI: 10.1007/s11605-015-2927-8. View